This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity | MicrobiomeTrials
← Back to trials NCT07497880
Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-04-06Est. Completion: 2027-07-07
Enrollment target: 320 participantsLocations Kailera Clinical Site, Chandler, Arizona, United States Kailera Clinical Site, Phoenix, Arizona, United States Kailera Clinical Site, Irvine, California, United States Kailera Clinical Site, Lincoln, California, United States Kailera Clinical Site, Northridge, California, United States Kailera Clinical Site, Hamden, Connecticut, United States Kailera Clinical Site, Jacksonville, Florida, United States Kailera Clinical Site, Jupiter, Florida, United States Kailera Clinical Site, Pembroke Pines, Florida, United States Kailera Clinical Site, Decatur, Georgia, United States Kailera Clinical Site, Skokie, Illinois, United States Kailera Clinical Site, South Bend, Indiana, United States Kailera Clinical Site, Kenner, Louisiana, United States Kailera Clinical Site, Garden City, Michigan, United States Kailera Clinical Site, Jefferson City, Missouri, United States Kailera Clinical Site, Kansas City, Missouri, United States Kailera Clinical Site, Spartanburg, South Carolina, United States Other microbiome trials you might be interested in Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disease, often compounded by obesity, that leads to serious l…
Multiple Locations Est. completion Jan 12, 2027
Obesity
A 12-month randomized, controlled, parallel-arm trial, divided into 2 consecutive periods: (1) 6-month weight loss perio…
Chicago, United States Completed Feb 1, 2025
Type 2 Diabetes Mellitus (T2DM)
Kailera Clinical Site, Knoxville, Tennessee, United States
Kailera Clinical Site, Austin, Texas, United States
Kailera Clinical Site, Austin, Texas, United States
Kailera Clinical Site, Brownsville, Texas, United States
Kailera Clinical Site, Farmers Branch, Texas, United States
Kailera Clinical Site, Mesquite, Texas, United States
Kailera Clinical Site, San Antonio, Texas, United States
Kailera Clinical Site, San Antonio, Texas, United States
Kailera Clinical Site, San Antonio, Texas, United States
Kailera Clinical Site, Sugar Land, Texas, United States
Kailera Clinical Site, Sandy City, Utah, United States
Kailera Clinical Site, Dee Why, New South Wales, Australia
Kailera Clinical Site, Miranda, New South Wales, Australia
Kailera Clinical Site, Wollongong, New South Wales, Australia
Kailera Clinical Site, Norwood, South Australia, Australia
Kailera Clinical Site, Altona N., Victoria, Australia Obesity (Disorder)
Overweight
Metabolic Syndrome
The goal of this clinical trial is to learn whether the NutriSteppe mobile application can improve blood sugar control a…
Almaty, Kazakhstan Est. completion Nov 2026